@article{0791cd535f7a4e03b1042bff8fb854f1,
title = "Psychiatry Milestones 2.0: Using the Supplemental Guide to Create a Shared Model of the Development of Professional Identity and Expertise",
author = "Kinzie, {J. Mark} and DeJong, {Sandra M.} and Laura Edgar and Houston, {L. Joy} and Furhut Janssen and Matthew Macaluso and Aoun, {Elie G.} and Lynneice Bowen and George Keepers and Bentman, {Adrienne L.} and Cowley, {Deborah S.}",
note = "Funding Information: Dr. Bentman reports non-financial support from Accreditation Council for Graduate Medical Education (ACGME) - Psychiatry Milestones 2.0 Work Group and non-financial support from ACGME/Psychiatry Review Committee - member, now Vice-Chair, outside the submitted work. Dr. DeJong reports she was Past President of AADPRT when Milestones 2.0 for Psychiatry were developed. Drs. Cowley, Houston, and Kinzie report non-financial support from the Accreditation Council for Graduate Medical Education. Dr. Macaluso has conducted clinical trials research as principal investigator for the following pharmaceutical companies over the last 12 months: (1) Acadia, (2) Allergan, (3) Alkermes, (4) AssureRx/Myriad, (5) Eisai, (6) Lundbeck, (7) Liva Nova, (8) Janssen, (9) Neurim, (10) Otsuka, (11) SAGE pharmaceuticals, and (12) Suven. All clinical trial and study contracts were with and payments made to either the University of Alabama at Birmingham Medical Center or the Kansas University Medical Center Research Institute. From April 2019 to June of 2020, Dr. Macaluso was a member of the speaker bureau for Janssen pharmaceuticals (Spravato/esketamine). Drs. Aoun, Bowen, Edgar, Janssen, and Keepers have nothing to disclose. ",
year = "2021",
month = aug,
doi = "10.1007/s40596-021-01455-6",
language = "English",
volume = "45",
pages = "500--505",
journal = "Academic Psychiatry",
issn = "1042-9670",
number = "4",
}